Nanosphere, which develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, that enables highly sensitive genomic and protein testing on a single platform, filed for an IPO Monday with the SEC. Credit Suisse is the lead manager on the deal. The firm filed to be traded on the NASDAQ under the ticker "NSPH." No terms were disclosed in the initial filing.
